US › Healthcare

Sanofi ADR (SNY)

US · Healthcare · Drug Manufacturers - General

$43.14+1.29%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$12.30B

Revenue YoY

+14.6%

Net profit

$343.0M

Profit YoY

-91.3%

EPS

$1.21

EPS estimate

$1.10

Net margin

2.8%

EPS came in at 1.21 against a street estimate of 1.10 — a beat of 10.0%.

Key statistics

Market cap

$102.36B

P/E

22.7

Forward P/E

8.5

P/B

1.28

Book value

$33.32

EPS (TTM)

$1.88

Dividend yield

9.61%

52-week high

$49.91

52-week low

$40.89

50-day MA

$43.91

200-day MA

$45.67

Beta

0.28

Analyst view

Analysts rate Sanofi ADR a buy (8 buy, 3 hold, 0 sell out of 11) with an average price target of $53.72.

Shareholding

Insiders

0.00%

Institutions

8.02%

Largest institutional holders

Fund	Stake
Dodge & Cox	1.17%
Morgan Stanley - Brokerage Accounts	0.52%
Fisher Asset Management, LLC	0.44%
Bank of America Corp	0.40%
Franklin Templeton Inc	0.30%
Amvescap Plc.	0.28%
JPMorgan Chase & Co	0.23%
Mondrian Investment Partners Ltd	0.21%

Corporate actions

Action	Detail	Date
Dividend	$2.42 / share ex-date May 4, 2026 · pay Jun 3, 2026	2026-05-04

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Sanofi ADR — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.